A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of treatment with an investigational
drug called clazakizumab compared to a placebo (inactive substance) in critically ill
patients.